- Home
- RYTM vs NWL Comparison
RYTM vs NWL Comparison
Compare RYTM & NWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- NWL
- Stock Information
- Founded
- RYTM 2008
- NWL 1903
- Country
- RYTM United States
- NWL United States
- Employees
- RYTM N/A
- NWL N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- NWL Plastic Products
- Sector
- RYTM Health Care
- NWL Industrials
- Exchange
- RYTM Nasdaq
- NWL Nasdaq
- Market Cap
- RYTM 3.1B
- NWL 3.6B
- IPO Year
- RYTM 2017
- NWL N/A
- Fundamental
- Price
- RYTM $59.03
- NWL $8.94
- Analyst Decision
- RYTM Strong Buy
- NWL Hold
- Analyst Count
- RYTM 10
- NWL 11
- Target Price
- RYTM $62.30
- NWL $9.10
- AVG Volume (30 Days)
- RYTM 701.0K
- NWL 5.9M
- Earning Date
- RYTM 11-05-2024
- NWL 10-25-2024
- Dividend Yield
- RYTM N/A
- NWL 3.14%
- EPS Growth
- RYTM N/A
- NWL N/A
- EPS
- RYTM N/A
- NWL N/A
- Revenue
- RYTM $112,530,000.00
- NWL $7,709,000,000.00
- Revenue This Year
- RYTM $63.95
- NWL N/A
- Revenue Next Year
- RYTM $43.24
- NWL $0.34
- P/E Ratio
- RYTM N/A
- NWL N/A
- Revenue Growth
- RYTM 81.55
- NWL N/A
- 52 Week Low
- RYTM $31.53
- NWL $5.39
- 52 Week High
- RYTM $68.58
- NWL $9.68
- Technical
- Relative Strength Index (RSI)
- RYTM 55.82
- NWL 57.82
- Support Level
- RYTM $55.37
- NWL $8.70
- Resistance Level
- RYTM $60.79
- NWL $9.40
- Average True Range (ATR)
- RYTM 3.60
- NWL 0.34
- MACD
- RYTM -0.27
- NWL -0.07
- Stochastic Oscillator
- RYTM 52.59
- NWL 35.63
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.
About NWL Newell Brands Inc.
Newell Brands Inc is an American global consumer goods company. The business activities of the group function through three segments namely, Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The learning and Development segment generates revenue for the firm which offers baby gear and infant care products; writing instruments, including markers and highlighters, pens, and pencils; art products; activity-based adhesive and cutting products, and labeling solutions.